BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:8020@myasthenia.org
DTSTART;TZID=America/New_York:20251113T140000
DTEND;TZID=America/New_York:20251113T140000
DTSTAMP:20251104T162836Z
URL:https://myasthenia.org/events/webinar-a-new-approach-to-treating-gener
 alized-myasthenia-gravis-kyy-101-car-t-cell-therapy/
SUMMARY:Webinar: A New Approach to Treating Generalized Myasthenia Gravis: 
 KYY-101 CAR T-cell Therapy 
DESCRIPTION:Thursday\, November 13\, 2025 2:00 PM Eastern Time / 11:00 AM P
 acific Time\nPresenters:\n\nProfessor Srikanth Muppidi\, MD – Clinical P
 rofessor\, Adult Neurology\, Stanford Medicine \n\nNaji Gehchan\, MD – 
 Chief Medical and Development Officer\, Kyverna  \nKyverna’s investiga
 tional CAR T-cell therapy\, KYV-101\, is a type of immunotherapy that is d
 ifferent than current treatments for generalized MG (gMG). It is a single 
 dose and works by using a person’s own immune cells to fight disease. Du
 ring this webinar\, we’ll learn more about how CAR T-cell therapies work
  and discuss an ongoing phase 3 clinical study\, called KYSA-6\, which is 
 evaluating KYV-101 for patients living with gMG. This study is open to tho
 se with AChR or MuSK+ MG\; for full criteria\, visit clinicaltrials.gov.\n
 \nRegister\nAfter registering\, you will receive a confirmation email cont
 aining information about joining the webinar. \n\nThis webinar is brought
  to you by Kyverna.
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/2025/1
 0/Muppidi-thumbnail-1.png
CATEGORIES:Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20251102T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR